Dibya Lochan Praharaj
Research Subjects
Dibya Lochan Praharaj has a total of 209 co-authors. Here are the top co-authors by number of shared publications:
Bipadabhanjan Mallick
Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar 751 024 India
11 shared publications- Anil Chandra Anand
Department of Gastroenterology & Hepatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 753024, India
10 shared publications Preetam Nath
Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar 751 024 India
9 shared publications- Preetam Nath
Department of Gastroenterology & Hepatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 753024, India
9 shared publications - Suprabhat Giri
Department of Gastroenterology & Hepatology, Kalinga Institute of Medical Sciences (KIMS), KIIT University, Bhubaneswar, 753024, India
9 shared publications - Bipadabhanjan Mallick
Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Bhubaneswar, India
7 shared publications
Latest Publications
- 15 July 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (6)
Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study
- 15 July 2026
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (6)
Validation of AGILE 3+ and AGILE 4 Scores for Assessing Advanced Fibrosis and Cirrhosis in Indian Patients With Nonalcoholic Fatty Liver Disease: An Indian Consortium on Non-alcoholic Fatty Liver Disease Study
- 27 April 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort
INTRODUCTION: Nosocomial infections (NIs) in cirrhosis are associated with high mortality but could be preventable. Logistic regression (LR) models have failed to identify high-risk patients. We aimed to develop machine learning (ML) models to predict NI. METHODS: The CLEARED consortium consists of prospectively enrolled cirrhosis inpatients from >120 centers. Using day-of-admission clinical data, 3 ML approaches (random forest [RF], extreme gradient boosting, and neural networks [NNs]) were used to predict NI. Data were split 80:20 for training and testing stratified by the outcome. Models were compared using area under the receiver operating characteristic curve (AUC). RESULTS: In total, 8,263 patients (55.90 ± 13.34 years; 64.1% men) from 127 centers in 37 countries were included. NI developed in 869 (10.5%), a median of 6 (4–11) days of postadmission. Major NIs were respiratory (29.6%) and urinary tract infection (15.7%), and spontaneous bacterial peritonitis (13.5%). NIs occurred more frequently in patients from low/low-middle income countries and those with severe liver disease, alcohol etiology, and admission infections. NIs were associated with inpatient mortality (31.9% vs 8.1%, P < 0.001) and liver transplantation (4.8% vs 1.9%, P < 0.001). Although the RF model (AUC 0.69) showed good calibration (Brier score 0.09), outperforming extreme gradient boosting, neural network, and LR models (AUC 0.66 for all; LR comparison P = 0.043), no model achieved AUC ≥0.80 for clinical utility. At 10% predicted probability threshold, the RF model demonstrated only 75.4% sensitivity, 52.9% specificity, and 15.9% positive predictive value (PPV). DISCUSSION: NIs cannot be accurately predicted from day-of-admission data using ML models, even in a large, prospective, global cirrhosis cohort. Every hospitalized patient with cirrhosis should receive protocolized infection control measures.
- 27 April 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Machine Learning Models Using Hospital Admission Characteristics Do Not Optimally Predict Nosocomial Infection Development in a Global Cirrhosis Cohort
INTRODUCTION: Nosocomial infections (NIs) in cirrhosis are associated with high mortality but could be preventable. Logistic regression (LR) models have failed to identify high-risk patients. We aimed to develop machine learning (ML) models to predict NI. METHODS: The CLEARED consortium consists of prospectively enrolled cirrhosis inpatients from >120 centers. Using day-of-admission clinical data, 3 ML approaches (random forest [RF], extreme gradient boosting, and neural networks [NNs]) were used to predict NI. Data were split 80:20 for training and testing stratified by the outcome. Models were compared using area under the receiver operating characteristic curve (AUC). RESULTS: In total, 8,263 patients (55.90 ± 13.34 years; 64.1% men) from 127 centers in 37 countries were included. NI developed in 869 (10.5%), a median of 6 (4–11) days of postadmission. Major NIs were respiratory (29.6%) and urinary tract infection (15.7%), and spontaneous bacterial peritonitis (13.5%). NIs occurred more frequently in patients from low/low-middle income countries and those with severe liver disease, alcohol etiology, and admission infections. NIs were associated with inpatient mortality (31.9% vs 8.1%, P < 0.001) and liver transplantation (4.8% vs 1.9%, P < 0.001). Although the RF model (AUC 0.69) showed good calibration (Brier score 0.09), outperforming extreme gradient boosting, neural network, and LR models (AUC 0.66 for all; LR comparison P = 0.043), no model achieved AUC ≥0.80 for clinical utility. At 10% predicted probability threshold, the RF model demonstrated only 75.4% sensitivity, 52.9% specificity, and 15.9% positive predictive value (PPV). DISCUSSION: NIs cannot be accurately predicted from day-of-admission data using ML models, even in a large, prospective, global cirrhosis cohort. Every hospitalized patient with cirrhosis should receive protocolized infection control measures.
- 23 February 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- p. 1-11
Evaluation of spleen stiffness and liver stiffness as non-invasive predictors of esophageal varices in patients with cirrhosis of the liver
Background Although upper gastrointestinal endoscopy (UGIE) is the diagnostic gold standard for esophageal varices (EV), its invasive nature and limited accessibility present considerable challenges. This study aimed at evaluating liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) via transient elastography (TE) as the non-invasive indicators for the presence and severity of EVs in cirrhotic patients. Methods This prospective, cross-sectional, observational study enrolled patients with compensated cirrhosis undergoing UGIE for the presence and grading of EVs. LSM and SSM were performed using FibroScan®. Non-invasive markers, including APRI, FIB-4, liver stiffness-spleen size-to platelet ratio score (LSPS) and spleen stiffness-spleen size-to platelet ratio score (SSPS), were also computed. Diagnostic efficacy was assessed through area under receiver-operating characteristic curve (AUROC) analysis, sensitivity and specificity. Results EVs were identified in 52.3% of the 132 enrolled patients (55% small, 45% large). Significant differences in laboratory parameters and non-invasive markers were observed between patients with and without EVs and between those with small vs. large EVs. SSM demonstrated superior diagnostic performance for predicting any EVs compared to LSM (AUROC = 0.955 vs. 0.847). The combined assessment of LS and SS, LSPS and particularly SSPS exhibited excellent predictive accuracy, with SSPS (AUROC = 0.997) proving the most robust predictor for any EVs. All elastography parameters had excellent diagnostic performance for the prediction of large EVs with SSM and combined assessment of LS and SS having the highest accuracy (AUROC = 1.000 for both). Conclusion Both LSM and SSM are significantly associated with the presence and severity of EVs, with SSM exhibiting superior performance. The integration of these parameters, especially SSPS, further augments predictive accuracy. Graphical abstract
- 23 February 2026
- Published by Springer Nature in Indian Journal of Gastroenterology
- p. 1-11
Evaluation of spleen stiffness and liver stiffness as non-invasive predictors of esophageal varices in patients with cirrhosis of the liver
Background Although upper gastrointestinal endoscopy (UGIE) is the diagnostic gold standard for esophageal varices (EV), its invasive nature and limited accessibility present considerable challenges. This study aimed at evaluating liver stiffness measurement (LSM) and spleen stiffness measurement (SSM) via transient elastography (TE) as the non-invasive indicators for the presence and severity of EVs in cirrhotic patients. Methods This prospective, cross-sectional, observational study enrolled patients with compensated cirrhosis undergoing UGIE for the presence and grading of EVs. LSM and SSM were performed using FibroScan®. Non-invasive markers, including APRI, FIB-4, liver stiffness-spleen size-to platelet ratio score (LSPS) and spleen stiffness-spleen size-to platelet ratio score (SSPS), were also computed. Diagnostic efficacy was assessed through area under receiver-operating characteristic curve (AUROC) analysis, sensitivity and specificity. Results EVs were identified in 52.3% of the 132 enrolled patients (55% small, 45% large). Significant differences in laboratory parameters and non-invasive markers were observed between patients with and without EVs and between those with small vs. large EVs. SSM demonstrated superior diagnostic performance for predicting any EVs compared to LSM (AUROC = 0.955 vs. 0.847). The combined assessment of LS and SS, LSPS and particularly SSPS exhibited excellent predictive accuracy, with SSPS (AUROC = 0.997) proving the most robust predictor for any EVs. All elastography parameters had excellent diagnostic performance for the prediction of large EVs with SSM and combined assessment of LS and SS having the highest accuracy (AUROC = 1.000 for both). Conclusion Both LSM and SSM are significantly associated with the presence and severity of EVs, with SSM exhibiting superior performance. The integration of these parameters, especially SSPS, further augments predictive accuracy. Graphical abstract
- 20 January 2026
- Published by Springer Nature
- p. 129-144
Muscle Health in Liver Disease and Transplant: The Sarcopenia Link
- 20 January 2026
- Published by Springer Nature
- p. 129-144
Muscle Health in Liver Disease and Transplant: The Sarcopenia Link
- 20 January 2026
- Published by Springer Nature
- p. 187-216
Chronic Hepatitis B and C Infection
- 20 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (2) , 318-321
Melioidosis presenting as hepatosplenic abscesses: A case series
Melioidosis, caused by Burkholderia pseudomallei , is an under-recognised tropical infection that often produces visceral abscesses. Hepatosplenic involvement is less commonly described and can mimic pyogenic or tubercular disease and commonly affects patients with diabetes, alcohol use, or immuno-compromised conditions. We report a retrospective series of 10 culture-confirmed patients from a tertiary care centre in India presenting with liver or splenic abscesses diagnosed by imaging and culture. Treatment comprised intravenous meropenem or ceftazidime followed by oral trimethoprim–sulfamethoxazole. Close follow-up is essential to ensure eradication and reduce relapse.
- 20 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (2) , 318-321
Melioidosis presenting as hepatosplenic abscesses: A case series
Melioidosis, caused by Burkholderia pseudomallei , is an under-recognised tropical infection that often produces visceral abscesses. Hepatosplenic involvement is less commonly described and can mimic pyogenic or tubercular disease and commonly affects patients with diabetes, alcohol use, or immuno-compromised conditions. We report a retrospective series of 10 culture-confirmed patients from a tertiary care centre in India presenting with liver or splenic abscesses diagnosed by imaging and culture. Treatment comprised intravenous meropenem or ceftazidime followed by oral trimethoprim–sulfamethoxazole. Close follow-up is essential to ensure eradication and reduce relapse.
- 4 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (1) , 169-171
Hookworm as an overlooked cause of overt gastrointestinal bleeding: A case report
The majority of hookworm infestations are asymptomatic; however, an increased parasite burden can lead to symptoms ranging from abdominal pain to iron deficiency anaemia. Rarely, hookworm can lead to complications such as upper gastrointestinal bleeding or malnutrition.
- 4 November 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 56 (1) , 169-171
Hookworm as an overlooked cause of overt gastrointestinal bleeding: A case report
The majority of hookworm infestations are asymptomatic; however, an increased parasite burden can lead to symptoms ranging from abdominal pain to iron deficiency anaemia. Rarely, hookworm can lead to complications such as upper gastrointestinal bleeding or malnutrition.
- 26 August 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (1) , 103176
Budd–Chiari Syndrome and Pregnancy—A Review
- 26 August 2025
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 16 (1) , 103176
Budd–Chiari Syndrome and Pregnancy—A Review
- 4 June 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 55 (3) , 251-254
Secondary haemophagocytic lymphohistiocytosis associated with acute viral hepatitis A – A case series
Hepatitis A-associated haemophagocytic lymphohistiocytosis (HLH) is an uncommon but severe complication that arises from an exaggerated immune response triggered by multiple aetiology. HLH is characterised by excessive inflammation and tissue destruction due to abnormal immune activation, often leading to multi-organ failure and high mortality if not promptly diagnosed and treated. Although HLH is more commonly associated with other viral infections, its occurrence with hepatitis A virus (HAV) is rare and primarily documented through case reports. The present case series aims to report the clinical presentations, diagnostic challenges, treatment strategies and outcomes of five cases of HAV-associated HLH.
- 4 June 2025
- Published by SAGE Publications in Tropical Doctor
- Vol. 55 (3) , 251-254
Secondary haemophagocytic lymphohistiocytosis associated with acute viral hepatitis A – A case series
Hepatitis A-associated haemophagocytic lymphohistiocytosis (HLH) is an uncommon but severe complication that arises from an exaggerated immune response triggered by multiple aetiology. HLH is characterised by excessive inflammation and tissue destruction due to abnormal immune activation, often leading to multi-organ failure and high mortality if not promptly diagnosed and treated. Although HLH is more commonly associated with other viral infections, its occurrence with hepatitis A virus (HAV) is rare and primarily documented through case reports. The present case series aims to report the clinical presentations, diagnostic challenges, treatment strategies and outcomes of five cases of HAV-associated HLH.